Genmab — November 2019
-
Dara/rev/dex godkendt i EU
-
first problem was that the back-neck program was stuck in the back and forth at the same place in the neck and the program could only be closed by turning off the power. The second bible was with the large program neck-back-loins, it also ended with clinging to the neck back and forth and could not be ended without a power cut. The latest problem is, in the back-lumbar program, here the shake has disappeared so it only has massage, in the sequences where there is usually shaking there is a stay
-
-
GENMAB FÅR JA FRA EU-KOMMISSIONEN TIL DARZALEX-KOMBINATION
17:32
EU-Kommissionen har givet Genmab markedsføringstilladelse til Darzalex i kombination med kræftmidlet Revlimid og dexamethasone til behandling af voksne med nydiagnosticeret knoglemarvskræft.Det fremgår tirsdag aften af en fondsbørsmeddelelse fra selskabet.
Dermed følger EU-Kommissionen indstillingen fra CHMP, der er et udvalg under de europæiske sundhedsmyndigheder, EMA, som blev givet i oktober.
/ritzau/FINANS
-
Genmab steg 1% i USA efter nyheden...
-
Rizau Finans: Salget af Genmans kræftmiddel Darzalex steg i oktober til 174,7 mio. dollar, hvilket er omkring 11 pct. mere end måneden før, hv
or det solgte for 156,9 mio. dollar.Det viser tal fra amerikanske Symphony Health Solutions, som estimerer salget til institutionelle salgskanaler som blandt andet hospitaler og lægeklinikker.
-
ja det er et super tal
-
God morgen.
-
Er det ikke første gang at Ritzau melder disse tal ud?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind